Cancer Channel
Related Channels


Alemtuzumab is a drug approved to treat a specific kind of leukemia called B-cell chronic lymphocytic leukemia. It works by signaling the immune system to bind to a certain type of antigen in white blood cells, which causes the cancer cells to die. A healthcare provider administers this product via infusion in a healthcare setting. Infections, fever, and chills are among the reported side effects.

What Is Alemtuzumab?

Alemtuzumab (Campath®) is a prescription medication approved to treat a certain type of leukemia (cancer of the blood and bone marrow) known as B-cell chronic lymphocytic leukemia. It belongs to a group of drugs known as monoclonal antibodies.
(Click What Is Alemtuzumab Used For? for more information on this topic, including possible off-label uses.)

Side Effects of Alemtuzumab

Just like any medicine, alemtuzumab can cause side effects, some of which can be quite significant. In fact, most people who use the drug will experience some type of adverse reaction during treatment.
Your healthcare provider will give you medicines to help manage some of these side effects. Talk to your healthcare provider about strategies to prevent or treat any problems you may experience.
Common side effects of alemtuzumab include but are not limited to:
  • Decreased blood cell counts
  • Infection
  • Fever
  • Chills.
(Click Alemtuzumab Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
The Zen of Cancer Caregiving - Recharge Your Batteries!

Alemtuzumab Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.